Imbio
Healthcare Software · Minnesota, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1015 Glenwood Ave Fl 4, Minneapolis, Min...Phone Number
(612) 520-7360Website
www.imbio.comRevenue
$7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Imbio
Imbio specializes in AI-driven medical imaging analysis for lung and cardiothoracic conditions, enhancing personalized medicine through transformative diagnostic processes. Their products include algorithms for lung density and texture analyses, pulmonary hypertension assessments, and coronary calcification analysis, aimed primarily at physicians, health systems, and patients. The company collaborates with medical device and pharmaceutical companies to develop custom imaging solutions that support disease-specific therapies. Trusted globally, Imbio offers secure, scalable, and interoperable deployment options for improved patient care and management.Explore more
Imbio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Imbio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Imbio has new funding data
Imbio, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Imbio recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Imbio had a recent Job posting/layoffs
Check if Imbio has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Imbio
Check out if Imbio is spiking on competitors!
Product Launch: Get notified when Imbio launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Imbio
Compare insights from companies similar to Imbio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Imbio is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Imbio is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Imbio.
Imbio financials insights
Gather financial insights about Imbio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Private Equity
$1.1M
2017
Series A
$1.5M
2020
Debt
$150K
Imbio Tech Stack
A closer look at the technologies used by Imbio
Most Recent Scoops
Mergers & Acquisitions (M&A)
Funding
Imbio has received an SBA PPP loan for $150,000-350,000 from BankVista, supporting the retention of 8 jobs.
Funding
Imbio recently secured $1.5 million in a Series A funding round. Invenshure led the investment.
Funding
Funding
Funding
Imbio News & Media
Respiratory tech group 4DMedical to acquire US-based Imbio for up to $68m
Respiratory imaging technology company 4DMedical (ASX: 4DX) is acquiring US medtech Imbio in a deal that could be worth up to US45 million ($68.4 million) withImbio Partners with MEDICAL-NOTE to Expand Image Analysis Tool Offering to Clinicians across Italy
MINNEAPOLIS, Sept. 27, 2021 /PRNewswire/ -- Imbio, a medical imaging artificial intelligence (AI) provider for chronic lung and cardiothoracic diseases, and MEDICAL-NOTE, an applications and software company for surgical procedure management and multi-disciplinary team communication,...National Institute for Health and Care Excellence (NICE) releases Medtech Innovation Briefing (MIB) for Imbio's Lung Texture Analysis Algorithm
MINNEAPOLIS, Sept. 2, 2021 /PRNewswire/ -- Imbio, Inc. announced today that the National Institute for Health and Care Excellence, a public body of the Department of Health in England providing evidence-based technology recommendations by independent committees, released their Medtech...Olympus Makes SeleCT™ QCT Analysis Available Nationwide via the Nuance AI Marketplace to Increase Access to Spiration Valve System Therapy
CENTER VALLEY, Pa., July 27, 2021 /PRNewswire/ -- Olympus Corporation today announced the launch of SeleCT Connect™, a new program offering of its SeleCT™ Quantitative Computer Tomography (QCT) analysis service available immediately to more than 9,000 healthcare facilities in the U.S....
Read more news
Top Healthcare Software Companies
See more top companies
Frequently Asked Questions Regarding Imbio
Sign Up For FreeTo access detailed company insights
Imbio specializes in AI-driven medical imaging analysis for lung and cardiothoracic conditions, enhancing personalized medicine through transformative diagnostic processes. Their products include algorithms for lung density and texture analyses, pulmonary hypertension assessments, and coronary calcification analysis, aimed primarily at physicians,... Read More
